Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deep immune B and plasma cell repertoire in non-small cell lung cancer.
Patel AJ, Khan N, Richter A, Naidu B, Drayson MT, Middleton GW. Patel AJ, et al. Among authors: drayson mt. Front Immunol. 2023 Jun 15;14:1198665. doi: 10.3389/fimmu.2023.1198665. eCollection 2023. Front Immunol. 2023. PMID: 37398676 Free PMC article.
The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study.
Emery A, Moore S, Crowe J, Murray J, Peacock O, Thompson D, Betts F, Rapps S, Ross L, Rothschild-Rodriguez D, Arana Echarri A, Davies R, Lewis R, Augustine DX, Whiteway A, Afzal Z, Heaney J, Drayson MT, Turner JE, Campbell JP. Emery A, et al. Among authors: drayson mt. BMC Cancer. 2024 Feb 5;24(1):174. doi: 10.1186/s12885-024-11817-6. BMC Cancer. 2024. PMID: 38317104 Free PMC article.
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Cook G, Ashcroft AJ, Senior E, Olivier C, Hockaday A, Richards J, Cavenagh JD, Snowden JA, Drayson MT, de Tute R, Roberts L, Owen RG, Yong K, Garg M, Boyd K, Sati H, Gillson S, Cook M, Cairns DA, Parrish C; United Kingdom Myeloma Research Alliance. Cook G, et al. Among authors: drayson mt. Lancet Haematol. 2024 Nov;11(11):e816-e829. doi: 10.1016/S2352-3026(24)00249-7. Epub 2024 Sep 6. Lancet Haematol. 2024. PMID: 39250926 Free article. Clinical Trial.
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma.
Kaiser MF, Hall A, Walker K, Sherborne A, De Tute RM, Newnham N, Roberts S, Ingleson E, Bowles K, Garg M, Lokare A, Messiou C, Houlston RS, Jackson G, Cook G, Pratt G, Owen RG, Drayson MT, Brown SR, Jenner MW. Kaiser MF, et al. Among authors: drayson mt. J Clin Oncol. 2023 Aug 10;41(23):3945-3955. doi: 10.1200/JCO.22.02567. Epub 2023 Jun 14. J Clin Oncol. 2023. PMID: 37315268
Comparison of short- and long-term humoral immune responses to pneumococcal polysaccharide and glycoconjugate vaccines in an HIV-infected population.
Faustini SE, Hodson J, Birtwistle J, Whitelegg A, Masuka S, Singo M, Chigiga J, Shields A, Plant T, Drayson MT, Manavi K, MacLennan CA, Richter AG. Faustini SE, et al. Among authors: drayson mt. J Infect. 2024 Nov;89(5):106282. doi: 10.1016/j.jinf.2024.106282. Epub 2024 Sep 24. J Infect. 2024. PMID: 39326516 Free article.
234 results